Medibio Limited advises that Mr. Peter Carlisle has tendered his resignation from his position as Non-Executive Director and Lead Independent Director of the Company, effective on 10 June 2022, in order to focus his time and efforts on the activities of the Growth and Advocacy Advisory Board. Peter has made a considerable contribution to the Company over many years, and that he will continue to contribute as Chairman of the Company's Growth and Advocacy Board. Given the Company is moving into a critical time in the Company's development, Peter's expertise in directing the Growth and Advocacy Advisory Board will be significant.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.027 AUD | -3.57% | -10.00% | -10.00% |
05-02 | TrivarX Receives Firm Commitments for AU$2.5 Million Share Issuance; Shares Jump 27% | MT |
02-28 | TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.00% | 6.31M | |
+16.34% | 79.03B | |
+8.65% | 8.78B | |
-16.33% | 4.83B | |
+51.22% | 4.65B | |
+2.18% | 3.89B | |
+20.51% | 2.34B | |
-26.79% | 2.18B | |
+15.12% | 2.11B | |
-36.56% | 2B |
- Stock Market
- Equities
- TRI Stock
- News TrivarX Limited
- Medibio Limited Announces Executive Changes